HuagongsheHuagongshe Chemistry Print Report · For research reference only
Methyl 1-formylcyclopentanecarboxylate → Methyl 4-[2-(4-{[(4-isobutoxy-1,2-benzisoxazol-3-yl)oxy]methyl}piperidin-1-yl)ethyl]tetrahydro-2H-pyran-4-carboxylate
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Methyl 1-formylcyclopentanecarboxylate | HCID 10931680 | — |
| Reactant | methyl 4-(2-oxoethyl)tetrahydro-2H-pyran-4-carboxylate | HCID 58468045 | — |
| Reactant | 4-Isobutoxy-3-(piperidin-4-ylmethoxy)-1,2-benzisoxazole | HCID 69316977 | — |
| Product | Methyl 4-[2-(4-{[(4-isobutoxy-1,2-benzisoxazol-3-yl)oxy]methyl}piperidin-1-yl)ethyl]tetrahydro-2H-pyran-4-carboxylate | HCID 69317456 | — |
Reaction Steps
The title compound was prepared according to the procedure described in Step 3 of EXAMPLE 2 using 4-isobutoxy-3-(piperidin-4-ylmethoxy)-1,2-benzisoxazole (EXAMPLE 10, Step 1) and methyl 4-(2-oxoethyl)tetrahydro-2H-pyran-4-carboxylate (WO 2004/043958) instead of 3-(piperidin-4-ylmethoxy)-4-(2,2,2-trifluoroethoxy)-1,2-benzisoxazole and methyl 1-formylcyclopentanecarboxylate.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08816090B2 |
| Source dataset | uspto-grants-2014_08 |
| ORD ID | ord-50923b9733dc41e0b4cc698de11445b0 |
| Source note | uspto-grants-2014_08 |